FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to a 2H-chromen compound or a derivative thereof having action of a S1P1 agonist. The above may be used for preventing and/or treating a disease caused by undesired lymphocyte filtration, or a disease caused by abnormal cell proliferation or accumulation.
EFFECT: preparing the compounds for preventing and/or treating the disease caused by undesired lymphocyte filtration, or the disease caused by abnormal cell proliferation or accumulation.
8 cl, 131 tbl, 156 ex
Title | Year | Author | Number |
---|---|---|---|
HETEROCOMPOUND | 2007 |
|
RU2425832C2 |
AZA-RING BRIDGED COMPOUND | 2008 |
|
RU2441868C2 |
MODULATORS OF ATP-BINDING TRANSPORTERS | 2010 |
|
RU2552353C2 |
PRODRUGS OF HIV REVERSE TRANSCRIPTASE INHIBITORS | 2015 |
|
RU2693622C2 |
PRODRUGS OF CONJUGATED BICYCLIC C5aR ANTAGONISTS | 2019 |
|
RU2794327C2 |
HETEROCYCLIC DERIVATIVES AND USE THEREOF | 2015 |
|
RU2711502C2 |
SUBSTITUTED BENZENE COMPOUNDS | 2012 |
|
RU2629118C2 |
TRKA KINASE INHIBITORS, COMPOSITIONS BASED THEREON AND METHODS | 2015 |
|
RU2672583C2 |
TREATING OR PREVENTING PROLIFERATIVE CONDITIONS | 2010 |
|
RU2705548C2 |
MODULATORS CCR2 | 2016 |
|
RU2726206C2 |
Authors
Dates
2013-08-20—Published
2009-12-04—Filed